Strategic complementarity in e-health, data science and epidemiology, serving the health of populations.
As part of the acceleration of Epiconcept's development, the 4 partners [Loïc Flachet, Guillaume Jeannerod, Valérie Nancey and Etienne Sévin] have decided to open Epiconcept's capital to a new shareholder, which will be made official in September 2024.
The choice fell on a complementary player in the health sector and sharing the same vision of the profession: Softway Medical Group.
Discover the press release:
